To develop a new pharmacological chaperones therapeutic strategy for Fabry disease by using Fabry disease mice model
碩士 === 國立陽明大學 === 臨床醫學研究所 === 106 === Fabry disease (FD) is an X-linked lysosome storage disease (LSD) due to the mutation of α-galactosidase A (GLA) gene. GLA participates in the metabolism of glycosphingolipids and is responsible for the breakdown of globotriaosylceramide (Gb3). The impairment o...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/w3uay9 |